Reversal of transcriptional silencing by T-cell activation. (A) Activation of purified resting CD4+ T lymphocytes. Prior to activation, resting CD4+ T lymphocytes were labeled with CFSE. Proliferation was measured by a twofold dilution of CFSE. After activation, lymphocytes were harvested at 16 h (- - - -), 24 h (-----), 40 h (-○-○-○), 52 h (-·-·-·), 64 h (——), and 72 h (), and CFSE fluorescence was measured. When resting CD4+ T lymphocytes were incubated in culture medium alone, no dilution of CFSE label was observed (not shown). In all experiments, >95% of CFSE-labeled lymphocytes underwent at least one cell division by day 3 postactivation. (B) Surface expression of CD69, CD25, and HLA-DR in HIV-1 DNA-positive cells measured immediately prior to and at the indicated times after activation. (C) Assay for MS HIV-1 mRNAs associated with activated CD4+ T lymphocytes. The sensitivity of the nested RT-PCR assay was assessed using in vitro-transcribed MS RNA standards. These standards were serially diluted into the lysates from activated CD4+ T lymphocytes harvested at various time points (0, 3, and 6 days) after activation. At 0.5 copy of MS RNA standard in the final nested reaction, the nested assay is positive in one of two duplicated reactions. At 0.05 copy per reaction, the PCR signals were consistently negative. (D) Reversal of HIV-1 latency in a fraction of HIV-1 DNA-positive resting CD4+ T lymphocytes after activation. Resting CD4+ T lymphocytes were seeded at approximately 10 HIV-1 DNA-positive lymphocytes per well and activated. Lymphocytes were harvested 2 to 5 days postactivation and analyzed for MS mRNA. Induced transcription of MS HIV-1 mRNA was detected in resting CD4+ T lymphocytes isolated from all patients. Representative positive wells are shown. The amplified spliced mRNA species from patients' samples had sizes ranging from 267 to 700 bp, as expected on the basis of the MS variants produced during infection (Fig. 2A).